INTRODUCTION
============

The objectives of mechanical ventilation are to improve gas exchange, reduce the work of breathing and relieve patient discomfort. Patient-ventilator asynchrony (PVA), given by the disparity between the needs of the patient and the time, flow, volume, or pressure provided by the ventilator,^([@r1])^ can hinder the fulfillment of these objectives. Therefore, the patient's adaptation to the ventilator is a crucial step to achieve ventilatory goals.

In patients with invasive mechanical ventilation, the type and frequency of PVA is determined by the presence or absence of inspiratory effort. Patient-ventilator asynchrony is low in patients with optimal neuromuscular blockade, which is only used in the first hours in cases of severe respiratory compromise.^([@r2])^ However, the remaining ventilation period involves patients making inspiratory effort, and it is at these times that PVA is observed more frequently. The problem is more complex when considering the different ventilation modes available and the use of sedation.

Patient-ventilator asynchrony requires special attention because it is associated with an increased need for sedatives, work of breathing, injury to respiratory muscles, alterations in the ventilation/perfusion ratio, intrinsic positive end-expiratory pressure, prolonged ventilation time, prolonged stay, and higher mortality and health costs.^([@r3])^ Ventilator-associated lung injury (VALI) is one of the main mechanisms currently linked to clinical outcomes in ventilated patients.^([@r4])^ Spontaneous inspiratory effort can be superimposed to mandatory ventilation producing increased transpulmonary pressure; the relationship between spontaneous and mandatory ventilation determines alveolar aeration and pulmonary tissue strain. Patient-ventilator asynchrony exposes the lungs to greater strain, alveolar overdistension, or cyclic collapse of poorly aerated regions, which induces tissue inflammation and the development of VALI.^([@r5],[@r6])^

Pioneering studies in patients with invasive ventilation focused on the analysis of the specific types of PVA at the beginning of ventilation.^([@r7],[@r8])^ Recently, Blanch et al. found a stronger relationship between PVA and mortality.^([@r9])^ The objectives of the present study were to identify the relationship of PVA with sedation level and hemogasometric and clinical outcomes in critically ventilated patients with inspiratory effort.

METHODS
=======

A prospective study was conducted in the intensive care unit (ICU) 8B of the *Hospital Clínico Quirúrgico "Hermanos Ameijeiras"* from July 2017 to February 2019. This is a university center with a total of 630 beds and is a reference center in Havana, Cuba. The ICU-8B has 12 beds and provides health care to approximately 350 medical and surgical patients per year. The present study was conducted according to the principles of the Declaration of Helsinki and was approved by the Scientific Council and the Ethics Committee for Scientific Research of the hospital. Informed consent was obtained from all participating patients.

During the study period, 421 patients were admitted to the ICU. The 196 patients who required invasive mechanical ventilation were included. The exclusion criteria were as follows: patients with invasive ventilation ≤ 24 hours, because short ventilation periods make difficult to interpret the relationship of PVA with clinical outcomes; patients from another ICU, as health care in another ICU can affect clinical outcomes; and patients without inspiratory effort due to the use of neuromuscular blockers, neuromuscular disease, or catastrophic brain injury, as this can influence the appearance of PVA (Figure 1S - Supplementary material).

Within the first 24 hours after starting mechanical ventilation, the following variables were collected: age, sex, weight, body mass index, type of patient, reason for invasive ventilation, sepsis/septic shock, use and dose of vasoactive drugs, need for renal replacement therapy, Sequential Organ Failure Assessment (SOFA) scale, and Acute Physiology and Chronic Health Evaluation (APACHE) II scale.

Patients were ventilated with the Evita 4, Evita XL (Dräger, Lübeck, Germany), Savina (Dräger, Lübeck, Germany), Bellavista 1000 (imtmedical, Switzerland), or SERVO-air 2.1 ventilator (Maquet, Röntgenvägen, Sweden). The ICU medical team knew about the data collection but not the objectives of the research. The ventilatory adjustments and medical treatment of the patients were left to the attending physician. The presence of PVA in the first 7 days of ventilation was evaluated daily. In each evaluation, the pressure-time, flow-time, and volume-time curves were recorded digitally (Canon PowerShot SX 530 16-megapixel camera) for 30 minutes. In all cases, it was guaranteed that no diagnostic or therapeutic intervention (including modifications to the ventilatory parameters and aspiration of the artificial airway) would be performed 30 minutes before the evaluations.

In each evaluation, the following hemogasometric variables were recorded: arterial oxygen pressure (PaO~2~), arterial oxygen saturation (SaO~2~), pH, arterial pressure of carbon dioxide (PaCO~2~) and bicarbonate (HCO~3~^-^), PaO~2~/inspiratory fraction of O~2~ ratio (PaO~2~/FiO~2~), alveolar oxygen pressure (P~A~O~2~), PaO~2~/P~A~O~2~ ratio, oxygenation index (OI = FiO~2~ × mean airway pressure/PaO~2~), alveolar-to-arterial oxygen difference (D~A-a~O~2~), shunt fraction (Qs/Qt = 100 × 0.0031 × D~A-a~O~2~/(0.0031 × D~A-a~O~2~) + 5), and ventilation index (VI = RR × (peak inspiratory pressure - PEEP) × PaCO~2~/1.000). Variables related to sedation were the use and dose of sedative and the Richmond Agitation-Sedation Scale score (RASS; agitated ≥ 1 point; awake and calm/light sedation 0 to -2 points; and deep sedation ≤ -3 points).^([@r10])^

The clinical response variables evaluated were ΔSOFA (SOFA on the 3rd, 5th, and 7th days of ventilation - SOFA of the day of initiation of ventilation), ventilator-associated pneumonia (VAP), failure of the spontaneous breathing test (clinical or hemogasometric signs of intolerance during two hours of testing),^([@r11])^ ventilation time, length of ICU stay, and ICU mortality.

Assessment of patient-ventilator asynchrony
-------------------------------------------

The pressure-time, flow-time and volume-time curves were evaluated breath by breath by two different physicians to identify the presence of PVA (kappa index = 0.87). Three types of PVA and their respective subtypes were explored: trigger asynchrony (ineffective trigger, auto-trigger, and double trigger); flow asynchrony (insufficient flow and excessive flow); and cycling asynchrony (premature cycling and delayed cycling) (Figures 2S to 8S - Supplementary material).^([@r12],[@r13])^ The asynchrony index (AI) was defined as the number of asynchronous events divided by the number of respiratory cycles (initiated by the patient or by the ventilator) and multiplied by 100; AI ≥ 10% was used to identify patients with severe PVA. This value was associated with poor results in previous studies.^([@r14])^

The duration of severe PVA can influence clinical outcomes, so persistent severe PVA was defined as AI ≥ 10% on the day of ventilation that persisted on days 3, 5, and 7 of ventilation.

Statistical analysis
--------------------

For the statistical analysis, the ventilation modes were grouped into volume- assist/controlled mode (V-A/C): volume-controlled ventilation + trigger (Bellavista 1000 and SERVO-air 2.1) and intermittent positive pressure ventilation (IPPV) + trigger (Evita 4, Evita XL and Savina); pressure-assist/controlled mode (P-A/C): pressure-controlled ventilation + trigger (Bellavista 1000 and SERVO-air 2.1), pressure-regulated volume-controlled ventilation + trigger (SERVO-air 2.1), and IPPV with autoflow + trigger (Evita 4, Evita XL and Savina); mixed mode: ventilation with bilevel positive airway pressure + pressure-supported ventilation (PSV) (Evita 4, Evita XL and Savina, Bellavista 1000 and SERVO-air 2.1) and synchronized intermittent mandatory ventilation + PSV (Evita 4, Evita XL and Savina, Bellavista 1000 and SERVO-air 2.1); and 4); and assist mode: PSV (Evita 4, Evita XL and Savina, Bellavista 1000 and SERVO-air 2.1).

The categorical variables are shown as counts and percentages. The quantitative variables are expressed as the mean with standard deviation (SD) or median with interquartile range (IQR), according to the normality of the population (evaluated with the Kolmogorov-Smirnov test and the Q-Q graph). Differences between groups were evaluated using the chi-squared (χ^2^) test with Yates correction and Student's *t-*test for qualitative and quantitative variables, respectively.

To evaluate the relationship between sedation and severe PVA, a sensitivity analysis was performed to examine the individual and combined effects of sedative drugs. A subgroup analysis was also performed to explore the influence of the level of sedation on the AI of each PVA subtype, for which a one-way analysis of variance was performed. The homoscedasticity between the groups was verified with the Levene´s test. *Post hoc* Bonferroni correction was done to evaluate the differences in the mean AI between the particular categories of sedation level.

A multivariate logistic regression (MLR) model was used to identify the factors associated with mortality in the ICU. Variables with a p-value ≤ 0.05 in the univariate analysis were included in the initial model. The automated variable selection method by backward elimination was used. The results are shown as odds ratio (OR) with respective 95% confidence interval (95%CI) and p-value.

The impact of persistent severe PVA on clinical outcomes was evaluated by a multiple linear regression model for quantitative response variables with a normal distribution and by an MLR model for binary response variables. In both models, the variables associated with mortality in the ICU were used as confounding variables. The results of the MLR model are shown as described, and the multiple linear regression model uses the regression coefficient β, 95%CI, and p-value.

Statistical hypothesis tests were considered significant with a bilateral p-value \< 0.05. The statistical analysis was performed with the IBM^®^ SPSS^®^ 23.0 program (IBM, Armonk, NY, USA).

RESULTS
=======

A total of 122 patients with a mean age of 62.0 years (SD 15.9 years) were analyzed. Fifty-nine percent were admitted to the ICU for nonsurgical causes. A total of 60.7% of patients (n = 74) had sepsis; of these, 68.9% (n = 51) had septic shock and were given a mean daily dose of norepinephrine of 0.32µg/kg/minute (SD 0.24µg/kg/minute). A total of 19.7% of patients had pneumonia, and 36.9% had acute respiratory distress syndrome. Renal replacement therapy was required in 6.6% of cases. The average score on the SOFA scale was 5.5 points (SD 2.8 points) and on the APACHE II scale 19.1 points (SD 6.5 points). [Table 1](#t1){ref-type="table"} shows the general characteristics of the patients. The type of patient, sepsis, APACHE II score, and SOFA score were independent risk factors for death in the ICU (Tables 1S and 2S - Supplementary material).

###### 

Characteristics of patients on the day of starting invasive mechanical ventilation

  Characteristic                                                                  
  ------------------------------------------------------------------------------ -------------
  Age, years                                                                     62.0 ± 15.9
  Male sex                                                                       82 (67.2)
  Weight, kg                                                                     76.4 (11.7)
  BMI, kg/m^2^                                                                   23.2 (6.3)
  Type of patient                                                                 
      Surgical                                                                   50 (41.0)
      Nonsurgical                                                                72 (59.0)
  Reason for invasive mechanical ventilation [\*](#TFN11){ref-type="table-fn"}    
      Septic shock                                                               51 (41.8)
      Pneumonia                                                                  24 (19.7)
      Aspiration                                                                 4 (3.3)
      Acute respiratory distress syndrome                                        45 (36.9)
      Postoperative                                                              26 (21.3)
      Exacerbation of COPD/asthma                                                7 (5.7)
      Cardiogenic pulmonary edema                                                12 (9.8)
      Disorder of consciousness                                                  21 (17.2)
  SOFA, points                                                                   5.5 (2.8)
  APACHE II, points                                                              19.1 (6.5)
  Renal replacement therapy                                                      8 (6.6)
  Mechanical ventilation time, days                                              9.5 (9.9)
  CU stay, days                                                                  10.6 (9.6)
  Mortality in the ICU                                                           88 (72.1)

BMI - body mass index; COPD - chronic obstructive pulmonary disease; SOFA - *Sequential Organ Failure Assessment*; APACHE - *Acute Physiology and Chronic Health Evaluation*; ICU - intensive care unit.

The same patient could present more than one reason for requiring invasive mechanical ventilation. The results are expressed as the mean ± standard deviation or n (%).

The mean ventilation time was 9.5 days (SD 9.9 days). A total of 504 observations were made, with a median of 4.0 observations per patient (IQR 2.0 - 5.0 observations) and a total of 339,652 respiratory cycles (2,784 per patient and 674 per observation). Seventy-eight observations (15.5%) were made in tracheostomized patients.

Frequency of severe patient-ventilator asynchrony
-------------------------------------------------

Of the 504 observations, 152 (30.2%) were performed in volume-assist/controlled mode, 133 (26.4%) in pressure-assist/controlled mode, 80 (15.9%) in mixed mode, and 139 (27.6%) in assist mode.

The mean AI was 37.8% (SD 14.1-61.5%). In 235 observations (46.6%), severe PVA was found. In 73.2% of these, more than one type of PVA was detected. Severe PVA was more frequent in the volume-assist/controlled mode (61.8%) and in the pressure-assist/controlled mode (50.4%) ([Figure 1](#f1){ref-type="fig"}). The prevalence of severe PVA subtypes was ineffective trigger 13.3%, auto-trigger 15.3%, double trigger 5.2%, insufficient flow 13.5%, excessive flow 9.5%, delayed cycling 13.7%, and premature cycling 2.4%. [Figure 2](#f2){ref-type="fig"} shows the prevalence of severe PVA subtypes according to ventilation mode.

![Prevalence of severe patient-ventilator asynchrony (n = 122; 504 observations).\
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Relationship between sedation and severe patient-ventilator asynchrony
----------------------------------------------------------------------

A total of 230 (45.6%) observations were made in patients with sedative infusion. The average score on the RASS scale was -3.85 points (SD 1.65 points). In the 504 observations, the use of sedatives was not associated with the frequency of severe PVA (112/235; 47.7% *versus* 118/269; 43.9%; p = 0.394). Among the 230 observations performed in sedated patients, the level of sedation (p = 0.368) and the score on the RASS scale (p = 0.607) were not associated with severe PVA ([Table 2](#t2){ref-type="table"}). However, when the PVA subtypes were evaluated, a relationship was observed between the level of sedation and PVA due to ineffective triggering (p = 0.020), insufficient flow (p = 0.016), or premature cycling (p = 0.023) (Table 3S - Supplementary material). In the Bonferroni *post hoc* analysis, it was found that the frequency of PVA due to ineffective trigger was significantly higher in patients with deep sedation, while PVA due to insufficient flow and premature cycling was associated with agitated patients (Figures 9S and 10S - Supplementary material).

###### 

Relationship between sedo-analgesia and severe patient-ventilator asynchrony

  --------------------------------------------------------------------------------------------------------------------
  Variables                                                   Total\         Severe PVA\    No severe PVA\   p value
                                                              N~obs~ = 230   N~obs~ = 112   N~obs~ = 118     
  ----------------------------------------------------------- -------------- -------------- ---------------- ---------
  Level of sedation                                                                                          0.368

      Agitated                                                30 (13.0)      11 (9.8)       19 (16.1)         

      Light sedation                                          99 (43.0)      50 (44.6)      49 (41.5)         

      Deep sedation                                           101 (43.9)     51 (45.5)      50 (42.4)         

  RASS scale, points                                          -3.85 ± 1.65   -3.8 ± 1.6     -3.9 ± 1.7       0.607

  Midazolam                                                   186 (80.9)     98 (87.5)      88 (74.6)        0.020

      Dose, mg/kg/hour                                        0.17 ± 0.08    0.18 ± 0.08    0.16 ± 0.08      0.015

  Propofol                                                    52 (22.6)      17 (15.2)      35 (29.7)        0.014

      Dose, mg/kg/hour                                        1.64 ± 0.52    1.82 ± 0.50    1.56 ± 0.51      0.082

  Fentanyl                                                    16 (7.0)       9 (8.0)        7 (5.9)          0.713

      Dose, mg/kg/hour                                        6.6 ± 5.4      0.14 ± 0.09    0.07 ± 0.09      0.149

  Ketamine                                                    78 (33.9)      35 (31.3)      43 ± 36.4)       0.489

      Dose, mg/kg/hour                                        1.07 ± 0.50    1.07 ± 0.51    1.07 ± 0.49      0.992

  Sensitivity analysis                                                                                        

      Midazolam only                                          90 (39.1)      53 (47.3)      37 (31.4)        0.019

      Propofol only                                           26 (11.3)      9 (8.0)        17 (14.4)        0.188

      Fentanyl only [\*](#TFN13){ref-type="table-fn"}         0 (0.0)        0 (0.0)        0 (0.0)          \-

      Ketamine only                                           14 (6.1)       3 (2.7)        11 (9.3)         0.067

      Midazolam + fentanyl                                    14 (6.1)       9 (8.0)        5 (4.2)          0.353

      Midazolam + ketamine                                    60 (26.1)      30 (26.8)      30 (25.4)        0.932

      Midazolam + propofol                                    22 (9.6)       6 (5.4)        16 (13.6)        0.059

      Propofol + fentanyl [\*](#TFN13){ref-type="table-fn"}   0 (0.0)        0 (0.0)        0 (0.0)          \-

      Propofol + ketamine                                     4 (1.7)        2 (1.8)        2 (1.7)          1.000
  --------------------------------------------------------------------------------------------------------------------

PVA - patient-ventilator asynchrony; Nobs -number of observations; RASS scale - Richmond Sedation and Agitation Scale.

There were no cases with fentanyl alone or propofol + fentanyl. The results are expressed as n (%) or the mean ± standard deviation.

The use of midazolam (p = 0.020) and its dose (p = 0.015) were associated with a higher frequency of severe PVA, while propofol (p = 0.014) was associated with a lower frequency. The use and dose of fentanyl or ketamine was not significantly related to severe PVA ([Table 2](#t2){ref-type="table"}). In the sensitivity analysis, it was found that midazolam infusion (p = 0.019) was the only drug associated with a higher frequency of severe PVA ([Table 2](#t2){ref-type="table"}).

Relationship of severe patient-ventilator asynchrony with hemogasometric variables
----------------------------------------------------------------------------------

All subtypes of severe PVA were related to hemogasometric changes ([Table 3](#t3){ref-type="table"}). Compared with patients without PVA, all those who developed severe asynchrony (with the exception of PVA due to excessive flow) had a significantly lower PaO~2~/FiO~2~ ratio. Patients with severe PVA due to insufficient flow and delayed cycling showed significant differences in almost all hemogasometric variables compared with patients without severe PVA ([Table 3](#t3){ref-type="table"}).

###### 

Relationship of severe patient-ventilator asynchrony with hemogasometric variables (n = 122; 504 observations)

  --------------------------------- ---------------------------------------------- ------------------------------------------- ---------------------------------------------- ----------------------------------- ---------------------------------------------- --------------- -------
  **Severe trigger asynchronies**                                                                                                                                                                                                                                                
  **Variables**                     **No severe PVA (N~obs~ = 269)**               **Severe PVA due to ineffective trigger**   **Severe PVA by auto-trigger**                 ** Severe PVA by double trigger**                                                                  
  **N~obs~ = 67**                   **p value[\*](#TFN14){ref-type="table-fn"}**   **N~obs~ = 77**                             **p value[\*](#TFN14){ref-type="table-fn"}**   **N~obs~ = 26**                     **p value[\*](#TFN14){ref-type="table-fn"}**                   
  Hemogasometric parameters                                                                                                                                                                                                                                                      
      pH                            7.41 ± 0.07                                    7.40 ± 0.05                                 0.182                                          7.42 ± 0.09                         0.370                                          7.43 ± 0.06     0.160
      PaO~2~                        137.1 ± 42.9                                   136.0 ± 43.3                                0.851                                          135.2 ± 47.0                        0.738                                          119.6 ± 41.0    0.047
      SaO~2~                        98.5 ± 1.7                                     98.4 ± 2.1                                  0.719                                          98.1 ± 2.4                          0.175                                          96.0 ± 3.7      0.002
      PaCO~2~                       37.0 ± 10.1                                    35.3 ± 10.1                                 0.219                                          36.6 ± 10.0                         0.759                                          35.3 ± 5.3      0.166
      HCO~3~^-^                     23.0 ± 7.0                                     21.9 ± 6.0                                  0.238                                          22.7 ± 6.9                          0.740                                          22.7 ± 3.3      0.700
  Respiratory indices                                                                                                                                                                                                                                                            
      PaO~2~/FiO~2~                 307.5 ± 107.0                                  280.7 ± 85.6                                0.032                                          282.5 ± 86.2                        0.036                                          256.3 ± 100.7   0.020
      PAO~2~                        284.8 ± 81.7                                   313.2 ± 90.9                                0.013                                          305.2 ± 82.9                        0.055                                          293.9 ± 59.2    0.580
      PaO~2~/PAO~2~                 0.50 ± 0.18                                    0.46 ± 0.14                                 0.051                                          0.47 ± 0.11                         0.073                                          0.42 ± 0.17     0.031
      OI                            4.9 ± 2.3                                      4.6 ± 3.3                                   0.484                                          4.3 ± 3.0                           0.108                                          5.0 ± 3.1       0.874
      D~A-a~O~2~ (obs.- exp.)       127.1 ± 93.0                                   133.4 ± 69.2                                0.537                                          133.1 ± 70.2                        0.542                                          143.3 ± 73.0    0.389
      Qs/Qt                         9.3 ± 3.6                                      9.0 ± 4.7                                   0.627                                          8.9 ± 5.1                           0.521                                          9.6 ± 3.6       0.685
      Ventilation index             13.6 ± 7.9                                     13.0 ± 7.9                                  0.578                                          15.1 ± 9.1                          0.157                                          14.8 ± 5.1      0.287
  **Severe flow asynchronies**                                                                                                                                                                                                                                                   
  **Variables**                     **Severe PVA due to insufficient flow**        **Severe PVA due to excessive flow**                                                                                                                                                          
  **N~obs~ = 68**                   **p value[\*](#TFN14){ref-type="table-fn"}**   **N~obs~ = 48**                             **p value[\*](#TFN14){ref-type="table-fn"}**                                                                                                      
  Hemogasometric parameters                                                                                                                                                                                                                                                      
      pH                            7.45 ± 0.08                                    \< 0.0001                                   7.44 ± 0.09                                    0.032                                                                                              
      PaO~2~                        144.7 ± 56.2                                   0.301                                       142.6 ± 51.1                                   0.428                                                                                              
      SaO~2~                        97.6 ± 3.0                                     0.020                                       98.2 ± 1.4                                     0.249                                                                                              
      PaCO~2~                       31.8 ± 7.2                                     \< 0.0001                                   33.4 ± 9.9                                     0.023                                                                                              
      HCO~3~^-^                     18.8 ± 4.8                                     \< 0.0001                                   20.6 ± 6.7                                     0.028                                                                                              
  Respiratory indices                                                                                                                                                                                                                                                            
      PaO~2~/FiO~2~                 271.5 ± 102.0                                  0.013                                       303.0 ± 103.0                                  0.787                                                                                              
      PAO~2~                        316.7 ± 85.5                                   0.005                                       293.3 ± 52.7                                   0.352                                                                                              
      PaO~2~/PAO~2~                 0.43 ± 0.16                                    0.004                                       0.49 ± 0.16                                    0.719                                                                                              
      OI                            5.1 ± 2.9                                      0.599                                       4.8 ± 3.6                                      0.853                                                                                              
      D~A-a~O~2~ (obs. - exp.)      165.0 ± 87.7                                   0.003                                       127.4 ± 64.9                                   0.978                                                                                              
      Qs/Qt                         10.9 ± 4.5                                     0.008                                       8.4 ± 3.4                                      0.109                                                                                              
      Ventilation index             17.3 ± 7.0                                     \< 0.0001                                   14.4 ± 7.6                                     0.516                                                                                              
  **Severe cycling asynchronies**                                                                                                                                                                                                                                                
  **Variables**                     **Severe PVA due to delayed cycling**          **Severe PVA due to premature cycling**                                                                                                                                                       
  **N~obs~ = 69**                   **p value[\*](#TFN14){ref-type="table-fn"}**   **N~obs~ = 12**                             **p value[\*](#TFN14){ref-type="table-fn"}**                                                                                                      
  Hemogasometric parameters                                                                                                                                                                                                                                                      
      pH                            7.38 ± 0.08                                    0.002                                       7.37 ± 0.09                                    0.057                                                                                              
      PaO~2~                        119.4 ± 41.5                                   0.002                                       124.5 ± 47.1                                   0.322                                                                                              
      SaO~2~                        95.4 ± 1.5                                     \< 0.0001                                   98.0 ± 1.3                                     0.316                                                                                              
      PaCO~2~                       45.6 ± 9.6                                     \< 0.0001                                   41.6 ± 12.9                                    0.128                                                                                              
      HCO~3~-                       24.9 ± 5.8                                     0.038                                       25.8 ± 7.7                                     0.178                                                                                              
  Respiratory indices                                                                                                                                                                                                                                                            
      PaO~2~/FiO~2~                 274.9 ± 101.4                                  0.023                                       238.9 ± 64.7                                   0.029                                                                                              
      PAO~2~                        314.7 ± 94.8                                   0.009                                       302.2 ± 46.1                                   0.241                                                                                              
      PaO~2~/PAO~2~                 0.45 ± 0.17                                    0.038                                       0.40 ± 0.10                                    0.006                                                                                              
      OI                            6.7 ± 4.5                                      0.009                                       5.2 ± 2.9                                      0.662                                                                                              
      D~A-a~O~2~ (obs.- exp.)       152.8 ± 80.5                                   0.036                                       147.2 ± 26.9                                   0.047                                                                                              
      Qs/Qt                         11.2 ± 4.7                                     0.002                                       9.9 ± 1.2                                      0.158                                                                                              
      Ventilation index             16.1 ± 7.1                                     0.017                                       15.9 ± 6.7                                     0.322                                                                                              
  --------------------------------- ---------------------------------------------- ------------------------------------------- ---------------------------------------------- ----------------------------------- ---------------------------------------------- --------------- -------

p value compared with \"No severe PVA\". PVA - patient-ventilator asynchrony; Nobs -number of observations; PaO~2~ - arterial oxygen pressure; SaO~2~ - arterial oxygen saturation; PaCO~2~ - arterial pressure of carbon dioxide; HCO~3~^-^ - bicarbonate; FiO~2~ - inspiratory fraction of O~2~; PAO~2~ - alveolar oxygen pressure; OI - oxygenation index; D~A-a~O~2~ (obs. - exp.) - observed - expected alveolar - arterial difference of oxygen; Qs/Qt - shunt fraction.

Relationship of persistent severe patient-ventilator asynchrony with clinical outcomes
--------------------------------------------------------------------------------------

On the first day of ventilation, 44.3% (n = 54/122) of patients presented severe PVA. The persistence of severe PVA on the 3rd, 5th, and 7th days of ventilation was observed in 37.7% (n = 46/122), 30.3% (n = 37/122), and 22.1% (n = 27/122) of the cases, respectively. The relationship of persistent severe PVA and clinical outcomes was analyzed ([Table 4](#t4){ref-type="table"} and Table 4S - Supplementary material). In the multivariate analysis, the presence of severe PVA on the first day of ventilation was associated with longer ventilation time (p = 0.032) and increased mortality in the ICU (p = 0.019) ([Table 4A](#t4){ref-type="table"}). The persistence of severe PVA on the 3rd, 5th, and 7th days of ventilation was associated with higher ΔSOFA, ventilation time, VAP, length of ICU stay, and ICU mortality ([Table 4](#t4){ref-type="table"}).

###### 

Relationship of persistent severe patient-ventilator asynchrony with clinical results (multivariate analysis)

  ------------------------------------------------------------------------------------------------------------------------------ ------------------------- ------------------------ --------------------------------------------- ----------- -------------- -------
  **Severe patient-ventilator asynchrony on the 1^st^ day of invasive mechanical ventilation and persisting on the 3^rd^ day**                                                                                                                               
  **Variables**                                                                                                                  **1^st^ day (n = 122)**   **3^rd^ day (n = 92)**                                                                            
  **OR/*β*[\*](#TFN16){ref-type="table-fn"}**                                                                                    **95%CI**                 **p value**              **OR/*β*[\*](#TFN16){ref-type="table-fn"}**   **95%CI**   **p value**    
   SOFA ^[†](#TFN17){ref-type="table-fn"}^                                                                                        -                         -                        -                                            0.54        0.03 - 1.05    0.039
   Ventilator-associated pneumonia ^[‡](#TFN18){ref-type="table-fn"}^                                                            1.96                      0.75 - 5.07              0.168                                         2.48        0.91 - 6.79    0.076
   Failed SBT ^[‡](#TFN18){ref-type="table-fn"}^                                                                                 1.56                      0.54 - 4.50              0.415                                         3.73        0.88 - 15.79   0.073
   Ventilation time ^[†](#TFN17){ref-type="table-fn"}^                                                                           4.02                      0.35 - 7.70              0.032                                         4.12        0.04 - 8.20    0.048
   ICU stay ^[†](#TFN17){ref-type="table-fn"}^                                                                                   2.83                      -0.82 - 6.47             0.127                                         5.92        1.85 - 10.0    0.005
   Mortality in the ICU ^[‡](#TFN18){ref-type="table-fn"}^                                                                       4.88                      1.30 - 18.47             0.019                                         3.74        1.28 - 10.94   0.016
  **Persistent severe patient-ventilator asynchrony on the 5^th^ and 7^th^ day of invasive mechanical ventilation**                                                                                                                                          
  **Variables**                                                                                                                  **5^th^ day (n = 72)**    **7^th^ day (n = 50)**                                                                            
  **OR/*β*[\*](#TFN16){ref-type="table-fn"}**                                                                                    **95%CI**                 **p value**              **OR/*β*[\*](#TFN16){ref-type="table-fn"}**   **95%CI**   **p value**    
  **Δ**SOFA ^[†](#TFN17){ref-type="table-fn"}^                                                                                   1.58                      0.79 - 2.37              \< 0.0001                                     1.50        0.57 - 2.42    0.002
  Ventilator-associated pneumonia ^[‡](#TFN18){ref-type="table-fn"}^                                                             4.29                      1.34 - 13.74             0.014                                         5.50        1.26 - 24.06   0.024
  Failed SBT ^[‡](#TFN18){ref-type="table-fn"}^                                                                                  4.70                      1.01 - 21.89             0.048                                         5.66        0.93 - 34.92   0.060
  Ventilation time ^[†](#TFN17){ref-type="table-fn"}^                                                                            4.81                      0.13 - 9.48              0.044                                         6.15        0.18 - 12.11   0.044
  ICU stay ^[†](#TFN17){ref-type="table-fn"}^                                                                                    4.91                      0.57 - 9.24              0.027                                         6.65        1.24 - 12.07   0.017
  Mortality in the ICU ^[‡](#TFN18){ref-type="table-fn"}^                                                                        12.54                     3.17 - 49.58             \< 0.0001                                     6.94        1.43 - 33.70   0.016
  ------------------------------------------------------------------------------------------------------------------------------ ------------------------- ------------------------ --------------------------------------------- ----------- -------------- -------

OR - odds ratio; ***β*** - multiple linear regression coefficient; CI - confidence interval; SOFA - *Sequential Organ Failure Assessment*; SBT - spontaneous breathing test; ICU - intensive care unit.

Odds ratio for multivariate logistic regression analysis and ***β*** regression coefficient for multiple linear regression analysis.

Adjusted p-value for the type of patient, sepsis, *Acute Physiology and Chronic Health Evaluation* II score, and *Sequential Organ Failure Assessment* score by multiple linear regression.

Adjusted p-value for the type of patient, sepsis, Acute *Physiology and Chronic Health Evaluation* II score, and *Sequential Organ Failure Assessment* score using multivariate logistic regression.

DISCUSSION
==========

In the present prospective study, a varied cohort of critically ill ventilated patients with inspiratory effort was analyzed. The incidence of acute respiratory distress syndrome was higher than that described by Bellani et al. in a recent multinational study (36.9% *versus* 23.4%),^([@r15])^ which could be due to the high frequency of cases with risk factors,^([@r16])^ such as septic shock, pneumonia, and aspiration. Mortality in the ICU was high, even if the initial mean values of SOFA and APACHE II are considered, which was related to the complexity of the patients analyzed (e.g., 41.8% in septic shock, 36.9% with acute respiratory distress syndrome) and the appearance of complications associated with prolonged ventilation (incidence of VAP: 32.0%). These data are in line with the recent evidence of high mortality rates in patients with septic shock, acute respiratory distress syndrome, and VAP.^([@r16]-[@r18])^

Many respiratory cycles were explored, and 38% of them were asynchronous. In previous studies, the frequency of PVA oscillated between 3% and 38%, depending on the asynchrony detection method, the type of PVA investigated, the ventilatory mode, the presence of inspiratory effort, and respiratory mechanisms.^([@r9],[@r19]-[@r24])^

The frequency of severe PVA was higher than that described by other authors.^([@r7]-[@r9])^ These results are explained by the high frequency of respiratory disorders or septic shock in the patients analyzed, as well as the study design: only patients with inspiratory effort, analysis of a wide variety of types of PVA in various ventilation modes, and the long evaluation period (7 days). Most studies on PVA have analyzed patients who were relatively stable or had only one respiratory disorder in a few ventilation modalities (sometimes including cases with neuromuscular blockade) and who were observed for a short period.^([@r7]-[@r9],[@r19],[@r22],[@r23])^ In this study, evaluations were performed for several consecutive days, which represents the real context of the clinical course (day to day) of critically ill patients; consequently, we had a greater probability of detecting PVA.

An important finding of the present study was the association between deep sedation and PVA due to ineffective triggering. Recent studies have also described a higher frequency of PVA in patients with deep sedation than those who had light sedation.^([@r1],[@r25])^ Vignaux et al. showed that the ineffective trigger can be unnoticed during deep sedation.^([@r26])^ Therefore, clinical examination and analysis of ventilatory curves is mandatory. Moreover, because deep sedation is an independent risk factor for hospital death (OR 2.36; 95%CI 1.31 - 4.25),^([@r27])^ interaction with PVA may contribute to worsening clinical outcomes.

The drugs used for sedation can affect the impulse and respiratory pattern, as well as decrease the effort of the respiratory muscles during ventilation.^([@r28])^ Therefore, in addition to the level of sedation, the type of drug used can influence the incidence of PVA. As in other regions,^([@r29])^ midazolam was the most commonly used hypnotic in this study and the sedative drug that was most linked with the presence of severe PVA. Recently, de Haro et al. observed that sedatives (e.g., midazolam, propofol, lorazepam) alone or combined with opioids (e.g., morphine, fentanyl) did not improve the frequency of PVA over opioids alone. Additionally, optimization of opioid dose was associated with lower AI^([@r30])^ because opioids decrease neural expiratory time and respiratory rate, with little effect on inspiratory impulse or PVA.^([@r31])^ In a recent clinical trial in patients with difficult weaning, Conti et al. observed that light sedation with propofol or dexmedetomidine improved patient-ventilator synchrony.^([@r32])^ Therefore, although there is a lack of evidence to judge the individual effect of sedative drugs, the most important factor to consider is the level of sedation. It is important to note that Chanques et al. demonstrated that changes in ventilatory parameters were more effective than changes in the level of sedation in reducing the frequency of severe PVA.^([@r33])^ This suggests that in patients with PVA, the infusion of sedative drugs should only be indicated after optimizing the ventilatory parameters and controlling clinical problems such as pain, anxiety, delirium, or fever. For reasons of patient safety, bolus administration of sedatives is also justified when it is evident the patient is struggling with the ventilator.^([@r1])^

No previous study has aimed to evaluate the association between PVA and hemogasometric disorders, so knowledge about it is limited and comes from secondary analyses. Sometimes, patients with clinically significant hemogasometric changes (e.g., PaO~2~/FiO~2~ \< 150mmHg) were even excluded.^([@r8])^ Yonis et al. found that the reduction of AI by neurally adjusted ventilatory assist, compared with PSV, was associated with an increase in PaO~2~ (from 66.7mmHg to 77.4mmHg) and in the PaO~2~/FiO~2~ ratio (from 203mmHg to 254mmHg).^([@r34])^ In the present study, severe PVA affected hemogasometric parameters. Particularly important is the low PaO~2~/FiO~2~ ratio observed with most types and subtypes of severe PVA. Therefore, PVA should be controlled before assessing the severity of respiratory dysfunction. This may modify the epidemiology of acute respiratory distress syndrome and SOFA score.^([@r35],[@r36])^

Patient-ventilator asynchrony has been associated with poor clinical outcomes. Schmidt et al. observed that V-A/C ventilation was associated with a greater sensation of dyspnea (OR 4.77; 95%CI 1.60 - 4.3), which improved in 35% of patients after adjustment of ventilatory parameters. Additionally, the lack of improvement in dyspnea was related to failure of extubation (17% *versus* 40%; p = 0.034).^([@r37])^ This suggests that inadequately low inspiratory flow or tidal volume can cause dyspnea and asynchrony, which hinders the weaning process. Severe trigger asynchronies were correlated with longer ventilation time, ICU stay, and hospital stay in early studies.^([@r7],[@r8])^ Blanch et al. observed that patients with an AI \> 10% had a higher mortality rate in the ICU (14% *versus* 67%) and hospital (23% *versus* 67%), as well as a longer ventilation time (6 days *versus* 16 days).^([@r9])^ In these studies, only the presence/absence of severe PVA and its relationship with clinical outcomes were analyzed. In the present investigation, not only was the presence/absence of severe PVA associated with poor clinical outcomes (e.g., ventilation time and mortality with severe PVA on the first day of ventilation), but persistence during ventilation days was a more powerful prognostic factor (e.g., organ dysfunction, VAP, ventilation time, ICU stay, and ICU mortality).

Insufficient ventilatory support causes damage to the respiratory muscles by increasing the work of breathing and muscle fatigue, while excessive ventilatory support produces atrophy and apoptosis of muscle fibers.^([@r12])^ The ineffective *trigger* during expiration produces eccentric contraction of the diaphragmatic muscle fibers and damage to the respiratory muscles,^([@r38])^ which explains the failure of the spontaneous breathing test, the prolongation of the ventilation time,^([@r39])^ and the consequent VAP.^([@r18],[@r40])^ Sepsis and local inflammation contribute to organ dysfunction, prolonged stay, and mortality.^([@r41])^

The strengths of the study were that precise definitions of PVA were used based on the criteria currently in force;^([@r12])^ most types and subtypes of PVA were analyzed; the study was conducted in a center with a high standard of health care and in an ICU with qualified intensivists 24 hours a day, seven days a week; the study addresses a frequent problem in the care of critically ill patients with poorly defined clinical consequences at present.

The study also has limitations to take into account. First, no automatic asynchrony detection software was used, so human error could be present in their visual detection. Second, it was a monocentric study, so it can be difficult to generalize the results to other ICU with different characteristics. Third, a mixed cohort of surgical and nonsurgical patients with several clinical and pathophysiological disorders was analyzed, which could influence the results. Fourth, only daily evaluations were made that lasted 30 minutes. The presence and magnitude of PVA between evaluations could have an impact on clinical outcomes. Fifth, the patients were sedated with benzodiazepines, which could influence the frequency of PVA. Finally, the inspiratory effort of the patients was not objectively measured, so asynchrony by reverse trigger or delayed trigger was not evaluated, which could have been present and influenced the results. The work of breathing of the patients was also not evaluated, which is valuable information for a holistic interpretation of the pathophysiological disorders associated with PVA.

CONCLUSION
==========

Patient-ventilator asynchrony is a frequent disorder in patients with inspiratory effort, which is influenced by the level of sedation and type of sedative drugs. The association of patient-ventilator asynchrony with hemogasometric changes and clinical outcomes suggests the need for an active and frequent surveillance for its correction. Additional studies are required to confirm these results.

Supplementary Material
======================
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Click here for additional data file.
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